Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

3.

Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.

Hasebe T, Sasaki S, Imoto S, Ochiai A.

Virchows Arch. 2004 Jan;444(1):20-7. Epub 2003 Nov 18.

PMID:
14624360
6.

Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.

Hasebe T, Yamauchi C, Iwasaki M, Ishii G, Wada N, Imoto S.

Hum Pathol. 2008 Mar;39(3):427-36. doi: 10.1016/j.humpath.2007.07.016.

PMID:
18261627
7.
8.

Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy.

Tamura N, Hasebe T, Okada N, Houjoh T, Akashi-Tanaka S, Shimizu C, Shibata T, Sasajima Y, Iwasaki M, Kinoshita T.

Cancer Sci. 2009 Oct;100(10):1823-33. doi: 10.1111/j.1349-7006.2009.01264.x. Epub 2009 Jun 26.

9.

Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.

Hasebe T, Konishi M, Iwasaki M, Endoh Y, Nakagohri T, Takahashi S, Kinoshita T, Ochiai A.

Hum Pathol. 2005 Jun;36(6):655-64.

PMID:
16021572
10.

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.

Hasebe T, Tamura N, Iwasaki M, Okada N, Akashi-Tanaka S, Hojo T, Shimizu C, Adachi M, Fujiwara Y, Shibata T, Sasajima Y, Tsuda H, Kinoshita T.

Mod Pathol. 2010 Apr;23(4):581-92. doi: 10.1038/modpathol.2010.3. Epub 2010 Jan 29.

12.

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

Hasebe T, Iwasaki M, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Kinoshita T, Tsuda H.

Hum Pathol. 2011 Dec;42(12):1823-32. doi: 10.1016/j.humpath.2011.02.015. Epub 2011 Jun 17.

PMID:
21683981
14.

Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.

Hasebe T, Okada N, Iwasaki M, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Tsuda H, Kinoshita T.

Hum Pathol. 2010 May;41(5):706-15. doi: 10.1016/j.humpath.2009.10.015. Epub 2010 Jan 8.

PMID:
20060154
15.

Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.

Yamauchi C, Hasebe T, Iwasaki M, Imoto S, Wada N, Fukayama M, Ochiai A.

Hum Pathol. 2007 Feb;38(2):247-59. Epub 2006 Oct 23.

PMID:
17056095
16.

Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.

Sugiyama M, Hasebe T, Shimada H, Takeuchi H, Shimizu K, Shimizu M, Yasuda M, Ueda S, Shigekawa T, Osaki A, Saeki T.

Hum Pathol. 2015 Jun;46(6):906-16. doi: 10.1016/j.humpath.2015.03.001. Epub 2015 Mar 18.

PMID:
25890786
17.

Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.

Hasebe T, Iwasaki M, Hojo T, Shibata T, Kinoshita T, Tsuda H.

Cancer Sci. 2013 Sep;104(9):1252-61. doi: 10.1111/cas.12217. Epub 2013 Jul 25.

18.

Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.

Hasebe T, Iwasaki M, Akashi-Tanaka S, Hojo T, Shibata T, Kinoshita T, Tsuda H.

Am J Surg Pathol. 2011 Oct;35(10):1484-97. doi: 10.1097/PAS.0b013e318224ca28.

PMID:
21881484
19.

Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.

Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A.

Mod Pathol. 2002 May;15(5):502-16.

20.

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.

Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN.

Mod Pathol. 2007 Feb;20(2):183-91. Epub 2007 Jan 5.

Supplemental Content

Support Center